Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 Inhibition
Ping Zhang(Ningbo University), Siok‐Keen Tey(The University of Queensland), Kathleen S. Ensbey(Fred Hutch Cancer Center), José Paulo Martins(The University of Queensland), Corey Smith(QIMR Berghofer Medical Research Institute), Rachel D. Kuns(QIMR Berghofer Medical Research Institute), Christopher E. Andoniou(Lions Eye Institute), Benjamin A. McEnroe(QIMR Berghofer Medical Research Institute), Adaeze Ekwe(QIMR Berghofer Medical Research Institute), Michael Boeckh(Fred Hutch Cancer Center), Andrea Henden(The University of Queensland), Alda Saldan(The University of Queensland), Glen Kennedy(Royal Brisbane and Women's Hospital), Geoffrey R. Hill(University of Washington Medical Center), Stuart D. Olver(QIMR Berghofer Medical Research Institute), Christine R. Schmidt(Fred Hutch Cancer Center), Antiopi Varelias(The University of Queensland), Mariapia A. Degli‐Esposti(Lions Eye Institute), Peter Fleming(Lions Eye Institute)
Cited by 1
Related Papers
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
|Biology of Blood and Marrow Transplantation|2009|1.8k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k